Publishing research using ab10231? Please let us know so that we can cite the reference in this datasheet.

ab10231 has been referenced in 5 publications.

  • Kannappan R  et al. p53 Modulates the Fate of Cardiac Progenitor Cells Ex Vivo and in the Diabetic Heart In Vivo. EBioMedicine 16:224-237 (2017). PubMed: 28163043
  • Wile BM  et al. Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs. Nat Protoc 9:2411-24 (2014). PubMed: 25232937
  • Moberly SP  et al. Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus. Basic Res Cardiol 108:365 (2013). PubMed: 23764734
  • Donaldson C  et al. Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling. Circ Heart Fail 5:803-11 (2012). WB . PubMed: 23014131
  • Ho M  et al. Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting. Protein Eng Des Sel 24:247-53 (2011). PubMed: 21051321

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up